Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Nemolizumab for Atopic Dermatitis
Recruiting1 awardPhase 2
Hallandale Beach, Florida
This trial is testing nemolizumab, a medication, to see how it affects the body's ability to process other drugs. Nemolizumab has been previously studied for its effectiveness in treating atopic dermatitis. The study focuses on adults with moderate to severe atopic dermatitis, a skin condition. Researchers want to understand if nemolizumab changes how these patients' bodies handle a mix of common medications.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.